ReMed ApS: Financial statements 2024
CVR: 39182408
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ReMed ApS (CVR 39182408) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -20,139 and a net result of DKK -188,171 compared with DKK -195,481 the year before. Equity in the 2024 report amounted to DKK -1,223,112.
- Gross Profit
- DKK -20,139
- Profit/Loss
- DKK -188,171
- Equity
- DKK -1,223,112
- Total Assets
- DKK 5,519,735
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -20 t. | -188 t. | -1.2 mio. | - |
| 2023 | - | -32 t. | -195 t. | -1 mio. | - |
| 2022 | - | -40 t. | -198 t. | -839 t. | - |
| 2020 | - | -38 t. | -203 t. | -433 t. | - |
| 2019 | - | -40 t. | -183 t. | -230 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ReMed ApS has published its annual report for 2023. Gross profit came to DKK -31,863, and the net result was DKK -195,481.
About ReMed ApS
ReMed ApS is a Danish company of the type Anpartsselskab based in Rønde, founded in 2017. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Jette Søndergaard and Jørn Aagaard. The company is owned by AAGAARD GYNÆKOLOGISK KLINIK ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -10,750 and a net result of DKK -4,608,195 compared with DKK -188,171 the year before. Equity in the 2025 report amounted to DKK -5,831,307.